DRTECH issues 27 billion won convertible bonds causing up to 34% dilution, shareholder value at risk
DRTECH has decided to issue 27 billion won in 9th series convertible bonds with an initial conversion price of 1,360 won, adjustable down to a minimum of 952 won.
Up to 28.36 million new shares may be issued, representing a 33.97% dilution of existing shares. The adjustable conversion price could further increase dilution pressure given the current stock price of 1,220 won.
The funds will be used for facility investment of 7 billion won, working capital of 8 billion won, and debt repayment of 12 billion won, with a heavy focus on debt repayment rather than growth-oriented spending.
Counterparties include major securities firms such as Samsung Securities and NH Investment & Securities, which are credible institutions, but the bond terms pose significant dilution risk to shareholders.
[AI Summary]DRTECH's large-scale convertible bond issuance will cause up to 34% dilution, severely damaging existing shareholder value. The heavy allocation to debt repayment rather than growth initiatives further undermines the positive outlook. Investors should closely monitor dilution effects and potential conversion price adjustments.